Experts meet to spur on New Zealand's hepatitis C elimination plan
AbbVie (NYSE: ABBV), has brought together leading local and international experts to discuss New Zealand’s progress towards the World Health Organization (WHO) 2030 goal for hepatitis C (HCV) elimination
Source: nzdoctor.co.nz